Culture Shift: Rethinking Skin's Commensal Microflora in Cosmetic Formulation

A moisturizer that promises to "protect your skin's microbiome" is making a claim that, by the normal rules of cosmetic chemistry, is hard to keep. Preservative systems exist specifically to prevent microbial growth in a jar, and regulators require proof they work. Under ISO 11930, the challenge test standard referenced across the EU and widely used in the US, a formulation has to demonstrate it can knock down inoculated populations of E. coli, S. aureus, P. aeruginosa, C. albicans and A. brasiliensis. Staphylococcus is the same genus that anchors the "good bacteria" pitch on skin. A cream cannot kill it in the tube and nurture it on the face at the same time.

That tension, more than any single active ingredient, is the real formulation story behind the current wave of microbiome-branded skincare. The science that launched the category is solid. Elizabeth Grice and Julia Segre's 2011 review in Nature Reviews Microbiology mapped how bacterial communities differ by skin site, sebaceous, moist or dry, and by individual, ending any notion of a single universal "healthy" skin flora. Julia Oh's lab at the Jackson Laboratory has since pushed the picture further, finding that Staphylococcus epidermidis populations are genetically diverse within one person, descended from multiple founding strains, with that diversity itself possibly doing more for skin homeostasis than the presence of any one strain. A jar labeled with a single named bacterium sits awkwardly next to that finding.

Formulators have mostly answered the preservation problem by changing what goes in the bottle rather than how it gets preserved. Live probiotics are difficult to stabilize through a shelf life and legally risky to sell as skincare, since a product that claims to treat a disease state with a live organism can drift into FDA drug or biologic territory. Postbiotics sidestep both problems. Heat-killed bacteria, cell lysates and fermentation filtrates carry no live count to protect, so they formulate into a conventionally preserved product without contradiction. Estee Lauder's Advanced Night Repair, a formula that predates the microbiome marketing wave by decades, has long used Bifidobacterium ferment lysate without branding itself around the microbiome at all, suggesting the underlying chemistry arrived well before the category name did. Gallinee builds its line around a similar logic: deactivated Lactobacillus-family ferments paired with prebiotic fibers and a lactic-acid-adjusted pH, rather than any living culture.

The corporate history of AOBiome makes the regulatory line concrete. The company's ammonia-oxidizing bacteria spray was sold to consumers as the cosmetic brand Mother Dirt, while AOBiome itself pursued the same organism, B244, through FDA trials as a live biotherapeutic product for eczema, rosacea and acne. Same bacterium, two regulatory paths, depending on what gets claimed. That split is instructive for a category where "microbiome-friendly" has no legal definition in the US or EU. Into that gap has stepped MyMicrobiome, a Swiss and German certification body running roughly twenty separate standards for face, body, scalp, infant, vaginal, foot, acne-prone and eczema-prone skin, effectively writing the rulebook regulators have not.

None of this means the postbiotic pivot is a dead end, only that it is a practical one. Recent reviews in journals including Skin Research and Technology have converged on a more modest read of the clinical evidence: small trials, inconsistent outcome measures, and real but limited support for barrier and anti-inflammatory effects from inactivated ferments, alongside a persistent lack of proof that live topical probiotics do what their labels imply. There is also a quieter finding buried in that literature that undercuts the premise driving the whole trend: properly formulated conventional cosmetics, the ones without any microbiome claim on the label, do not appear to meaningfully disrupt the skin flora of healthy users to begin with. The chemistry problem the industry solved may have been smaller than the marketing problem it created.